ArticleCureus2026
Cranial Giant Cell Arteritis Presenting as Pyrexia of Unknown Origin: A Diagnostic Challenge With Negative PET-CT but a Positive Halo Sign.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant cell arteritis (GCA) classically presents with cranial symptoms, but systemic features may predominate and obscure the diagnosis. We report the case of a woman in her early 70s who presented with a six-week history of nausea, vomiting, anorexia, weight loss, and intermittent confusion, followed by persistent pyrexia during a prolonged inpatient admission. Extensive investigations for infection, malignancy, and systemic autoimmune disease were unrevealing, including computed tomography (CT) imaging, echocardiography, microbiological testing, autoimmune panels, and fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). She received five courses of broad-spectrum intravenous antimicrobial therapy without a clinical or biochemical response. Her C-reactive protein remained above 120 mg/L for several weeks. Despite the absence of new headache, jaw claudication, scalp tenderness, or visual symptoms, temporal artery ultrasound was requested because of concern for atypical GCA. This demonstrated bilateral incompressible echolucent halos, consistent with cranial GCA. Prednisolone 40 mg daily was commenced, after which the fever resolved within 48 hours, cognition normalised, and oral intake improved substantially. She was discharged after 51 days on a tapering corticosteroid regimen. This case emphasises that GCA should remain in the differential diagnosis of pyrexia of unknown origin in older adults with sustained systemic inflammation and a poor response to antimicrobial therapy, even when classical cranial symptoms are absent and FDG-PET/CT does not demonstrate large-vessel vasculitis. Early temporal artery ultrasound may reduce diagnostic delay, unnecessary antimicrobial exposure, and prolonged hospitalisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.